The engagement of a financial advisor to explore M&A opportunities usually indicates a proactive approach to growth and could result in positive market sentiment. Investors may anticipate potential deals that could enhance ReShape Lifesciences' market position and financial performance, leading to a likely increase in stock price in the short term.